The WACC of Woojung Bio Inc (215380.KQ) is 9.4%.
| Range | Selected | |
| Cost of equity | 7.40% - 11.40% | 9.40% |
| Tax rate | 22.10% - 22.30% | 22.20% |
| Cost of debt | 4.00% - 20.10% | 12.05% |
| WACC | 4.5% - 14.2% | 9.4% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.74 | 1.07 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.40% | 11.40% |
| Tax rate | 22.10% | 22.30% |
| Debt/Equity ratio | 2.08 | 2.08 |
| Cost of debt | 4.00% | 20.10% |
| After-tax WACC | 4.5% | 14.2% |
| Selected WACC | 9.4% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 215380.KQ:
cost_of_equity (9.40%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.74) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.